Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1951 1
1952 2
1953 2
1954 3
1955 4
1956 2
1958 1
1964 5
1965 23
1966 35
1967 66
1968 72
1969 86
1970 103
1971 110
1972 136
1973 175
1974 162
1975 148
1976 156
1977 164
1978 163
1979 195
1980 166
1981 198
1982 205
1983 261
1984 297
1985 313
1986 285
1987 267
1988 272
1989 377
1990 332
1991 367
1992 376
1993 418
1994 480
1995 482
1996 460
1997 544
1998 493
1999 519
2000 569
2001 586
2002 601
2003 698
2004 721
2005 762
2006 795
2007 870
2008 960
2009 1057
2010 1238
2011 1393
2012 1483
2013 1456
2014 1441
2015 1559
2016 1491
2017 1550
2018 1496
2019 1686
2020 1651
2021 1470
2022 1374
2023 1181
2024 607

Text availability

Article attribute

Article type

Publication date

Search Results

33,734 results

Results by year

Filters applied: . Clear all
Page 1
ECOG-ACRIN Guideline for Contouring and Treatment of Early Stage Anal Cancer Using IMRT/IGRT.
Damico N, Meyer J, Das P, Murphy J, Miller E, Koontz B, Hall W, McBride M, Pereira G, Catalano P, Chakravarthy AB, O'Dwyer PJ, Dorth J. Damico N, et al. Pract Radiat Oncol. 2022 Jul-Aug;12(4):335-347. doi: 10.1016/j.prro.2022.01.015. Pract Radiat Oncol. 2022. PMID: 35717050
PURPOSE: Previous anal cancer guidelines delineate target volumes similarly for all patients with squamous cell carcinoma of the anal canal and/or perianal skin (SCCA), regardless of disease stage. ...METHODS AND MATERIALS: A contouring atlas and radiation tr …
PURPOSE: Previous anal cancer guidelines delineate target volumes similarly for all patients with squamous cell carcinoma …
Xevinapant or placebo plus chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck: TrilynX phase III study design.
Bourhis J, Burtness B, Licitra LF, Nutting C, Schoenfeld JD, Omar M, Bouisset F, Nauwelaerts H, Urfer Y, Zanna C, Cohen EE. Bourhis J, et al. Future Oncol. 2022 May;18(14):1669-1678. doi: 10.2217/fon-2021-1634. Epub 2022 Feb 17. Future Oncol. 2022. PMID: 35172587
Xevinapant is a first-in-class antagonist of inhibitor of apoptosis proteins, which enhances cancer cell sensitivity to chemotherapy and radiotherapy. In a phase II randomized study in patients with unresected locally advanced squamous cell carcinoma o …
Xevinapant is a first-in-class antagonist of inhibitor of apoptosis proteins, which enhances cancer cell sensitivity to chemotherapy and rad …
Pembrolizumab given concomitantly with chemoradiation and as maintenance therapy for locally advanced head and neck squamous cell carcinoma: KEYNOTE-412.
Machiels JP, Tao Y, Burtness B, Tahara M, Licitra L, Rischin D, Waldron J, Simon C, Gregoire V, Harrington K, Alves GV, Figueiredo Lima IP, Pointreau Y, M Hughes BG, Aksoy S, Hetnal M, Ge JY, Brown H, Cheng J, Bidadi B, Siu LL. Machiels JP, et al. Future Oncol. 2020 Jun;16(18):1235-1243. doi: 10.2217/fon-2020-0184. Epub 2020 Jun 3. Future Oncol. 2020. PMID: 32490686
Current treatment guidelines for patients with locally advanced head and neck squamous cell carcinoma (HNSCC) recommend multimodal treatment, including chemoradiation therapy (CRT) or surgery followed by radiation, with or without chemotherapy. ...Clinical …
Current treatment guidelines for patients with locally advanced head and neck squamous cell carcinoma (HNSCC) recommend …
Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus.
Herskovic A, Martz K, al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V, Cooper J, Byhardt R, Davis L, Emami B. Herskovic A, et al. N Engl J Med. 1992 Jun 11;326(24):1593-8. doi: 10.1056/NEJM199206113262403. N Engl J Med. 1992. PMID: 1584260 Free article. Clinical Trial.
Recent studies have suggested that combined chemotherapy and radiation therapy may result in improved survival. METHODS: This phase III prospective, randomized, and stratified trial was undertaken to evaluate the efficacy of four courses of combined fluorouracil (10 …
Recent studies have suggested that combined chemotherapy and radiation therapy may result in improved survival. METHODS: This phase III pros …
Long-term Efficacy of Neoadjuvant Chemoradiotherapy Plus Surgery for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma: The NEOCRTEC5010 Randomized Clinical Trial.
Yang H, Liu H, Chen Y, Zhu C, Fang W, Yu Z, Mao W, Xiang J, Han Y, Chen Z, Yang H, Wang J, Pang Q, Zheng X, Yang H, Li T, Zhang X, Li Q, Wang G, Chen B, Mao T, Kong M, Guo X, Lin T, Liu M, Fu J. Yang H, et al. JAMA Surg. 2021 Aug 1;156(8):721-729. doi: 10.1001/jamasurg.2021.2373. JAMA Surg. 2021. PMID: 34160577 Free PMC article. Clinical Trial.
IMPORTANCE: The prognosis of patients with locally advanced esophageal squamous cell carcinoma (ESCC) remains poor after surgery. Neoadjuvant chemoradiotherapy (NCRT) has been shown to potentially improve survival. ...DESIGN, SETTING, AND PARTICIPANTS: The Ne …
IMPORTANCE: The prognosis of patients with locally advanced esophageal squamous cell carcinoma (ESCC) remains poor afte …
Immunotherapy for squamous cell carcinoma of the head and neck.
Yokota T, Homma A, Kiyota N, Tahara M, Hanai N, Asakage T, Matsuura K, Ogawa T, Saito Y, Sano D, Kodaira T, Motegi A, Yasuda K, Takahashi S, Tanaka K, Onoe T, Okano S, Imamura Y, Ariizumi Y, Hayashi R; Japan Clinical Oncology Group (JCOG) Head and Neck Cancer Study Group. Yokota T, et al. Jpn J Clin Oncol. 2020 Sep 28;50(10):1089-1096. doi: 10.1093/jjco/hyaa139. Jpn J Clin Oncol. 2020. PMID: 32776100 Review.
Squamous cell carcinoma of the head and neck is characterized by an immunosuppressive environment and evades immune responses through multiple resistance mechanisms. ...CheckMate141 and KEYNOTE-048 were practice-changing randomized phase 3 trials for p …
Squamous cell carcinoma of the head and neck is characterized by an immunosuppressive environment and evades immune res …
Multidisciplinary Therapy of Esophageal Cancer.
Egyud MR, Tseng JF, Suzuki K. Egyud MR, et al. Surg Clin North Am. 2019 Jun;99(3):419-437. doi: 10.1016/j.suc.2019.02.002. Epub 2019 Mar 30. Surg Clin North Am. 2019. PMID: 31047033 Review.
Response to induction therapy is an important prognostic marker. For esophageal squamous cell carcinoma, it may be acceptable to observe clinical complete responders after chemoradiotherapy and perform salvage esophagectomy for recurrent disease. Cl …
Response to induction therapy is an important prognostic marker. For esophageal squamous cell carcinoma, it may be acce …
Systemic therapy for advanced cutaneous squamous cell carcinoma.
Fitzgerald K, Tsai KK. Fitzgerald K, et al. Semin Cutan Med Surg. 2019 Mar 1;38(1):E67-E74. doi: 10.12788/j.sder.2019.010. Semin Cutan Med Surg. 2019. PMID: 31051028 Review.
The incidence of advanced cutaneous squamous cell carcinoma (cSCC) is increasing; of the 1.3 million nonmelanoma skin cancers that arise each year, approximately 20% are cSCC, and between 2-5% of these cases ultimately metastasize. ...Herein we provide a revi …
The incidence of advanced cutaneous squamous cell carcinoma (cSCC) is increasing; of the 1.3 million nonmelanoma skin c …
Medical treatment of advanced cutaneous squamous-cell carcinoma.
Gellrich FF, Hüning S, Beissert S, Eigentler T, Stockfleth E, Gutzmer R, Meier F. Gellrich FF, et al. J Eur Acad Dermatol Venereol. 2019 Dec;33 Suppl 8:38-43. doi: 10.1111/jdv.16024. J Eur Acad Dermatol Venereol. 2019. PMID: 31833610 Review.
Considering the rising incidence, cutaneous squamous-cell carcinoma (cSCC) has a high clinical relevance. In patients with localized cSCC, complete surgical resection is indicated. ...Altogether, PD-1 inhibitors are expected to become the new standard …
Considering the rising incidence, cutaneous squamous-cell carcinoma (cSCC) has a high clinical relevance. In pat …
Investigative Landscape in Advanced Non-Melanoma Skin Cancers.
Reddy P, Yao M, Patel M. Reddy P, et al. Curr Treat Options Oncol. 2021 Jun 7;22(7):56. doi: 10.1007/s11864-021-00853-0. Curr Treat Options Oncol. 2021. PMID: 34097150 Review.
Hedgehog inhibitors, vismodegib and sonidegib, remain upfront options for advanced or metastatic basal cell carcinomas. Current clinical trials are continuing to evaluate the use of immune checkpoint inhibitors and hedgehog pathway inhibitors. ...
Hedgehog inhibitors, vismodegib and sonidegib, remain upfront options for advanced or metastatic basal cell carcinomas. Current clinical …
33,734 results
You have reached the last available page of results. Please see the User Guide for more information.